| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| China Med Technolgs has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 28-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| China Medical Tech ADR | 6 |
$25 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | CHINA MEDICAL TECHNOLOGIES INC ADS (CMED=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | CHINA MEDICAL TECHNOLOGIES INC ADS (CMED=US) 12-months forecast | 1 |
$15 |
| 27-Nov-2009 | Validea |
N/A
| Validea Guru Analysis Report for CMED. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. | 0 |
$18 |
| 26-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for MEDICAL SUPPLIES | 18 |
$49 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Instrumentation Intelligence Monitor: overall outlook STRONG - 20 new Leaders; 12 new Laggards. | 47 |
$20 |
| 23-Nov-2009 | Thomson StreetEvents |
N/A
| CMED - Event Transcript of China Medical Technologies, Inc. conference call, Nov. 19, 2009 / 8:00am ET | 13 |
$75 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for CMED | 13 |
$25 |
| 23-Nov-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
1.48% Nasdaq 
Research Reports
